{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:17:53Z","timestamp":1790835473240,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fondation Ophtalmologique Adolphe de Rothschild"},{"DOI":"10.13039\/501100020398","name":"Fondation Philippe Chatrier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020398","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Association Amicale des Anciens Internes des Hopitaux de Paris"},{"DOI":"10.13039\/100014808","name":"Fondation Vaincre Alzheimer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021594","name":"Demensfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009673","name":"Gun och Bertil Stohnes Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017018","name":"Wallenberg Centre for Molecular and Translational Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-940244"],"award-info":[{"award-number":["AF-940244"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003792","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2021-0298"],"award-info":[{"award-number":["FO2021-0298"]}],"id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["A2020812F"],"award-info":[{"award-number":["A2020812F"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"International Society for Neurochemistry\u2019s Career Development Grant"},{"DOI":"10.13039\/100010773","name":"Demensf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aina Wallstr\u00f6ms and Mary-Ann Sj\u00f6bloms Foundation"},{"DOI":"10.13039\/501100007484","name":"Agneta Prytz-Folkes och G\u00f6sta Folkes Stiftelse","doi-asserted-by":"publisher","award":["2020-00124"],"award-info":[{"award-number":["2020-00124"]}],"id":[{"id":"10.13039\/501100007484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010107","name":"Anna-Lisa och Bror Bj\u00f6rnssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["2018-02532"],"award-info":[{"award-number":["2018-02532"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish State Support for Clinical Research","award":["ALFGBG-720931"],"award-info":[{"award-number":["ALFGBG-720931"]}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201809-2016862"],"award-info":[{"award-number":["201809-2016862"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AD Strategic Fund and the Alzheimer\u2019s Association","award":["ADSF-21-831376-C"],"award-info":[{"award-number":["ADSF-21-831376-C"]}]},{"DOI":"10.13039\/501100021720","name":"Olav Thon Stiftelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Familjen Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["860197"],"award-info":[{"award-number":["860197"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00415-023-12066-6","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T01:01:30Z","timestamp":1699664490000},"page":"1297-1310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Comparison of CSF and plasma NfL and pNfH for Alzheimer\u2019s disease diagnosis: a memory clinic study"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0761-7885","authenticated-orcid":false,"given":"Agathe","family":"Vrillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas K.","family":"Karikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"G\u00f6tze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Cognat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dumurgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Lilamand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,11]]},"reference":[{"key":"12066_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ceb.2020.10.011","volume":"68","author":"P Bomont","year":"2021","unstructured":"Bomont P (2021) The dazzling rise of neurofilaments: physiological functions and roles as biomarkers. Curr Opin Cell Biol 68:181\u2013191. https:\/\/doi.org\/10.1016\/j.ceb.2020.10.011","journal-title":"Curr Opin Cell Biol"},{"key":"12066_CR2","doi-asserted-by":"publisher","first-page":"a018309","DOI":"10.1101\/cshperspect.a018309","volume":"9","author":"A Yuan","year":"2017","unstructured":"Yuan A, Veeranna MVR, Nixon RA (2017) Neurofilaments and neurofilament proteins in health and disease. Cold Spring Harb Perspect Biol 9:a018309. https:\/\/doi.org\/10.1101\/cshperspect.a018309","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"12066_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40478-018-0649-3","volume":"7","author":"NJ Ashton","year":"2019","unstructured":"Ashton NJ, Leuzy A, Lim YM, Troakes C, Hortob\u00e1gyi T, H\u00f6glund K et al (2019) Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration. Acta Neuropathol Commun 7:5. https:\/\/doi.org\/10.1186\/s40478-018-0649-3","journal-title":"Acta Neuropathol Commun"},{"key":"12066_CR4","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","volume":"12","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Janelidze S, Al Khleifat A, Leuzy A, van der Ende EL, Karikari TK et al (2021) A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun 12:3400. https:\/\/doi.org\/10.1038\/s41467-021-23620-z","journal-title":"Nat Commun"},{"key":"12066_CR5","doi-asserted-by":"publisher","first-page":"fcac174","DOI":"10.1093\/braincomms\/fcac174","volume":"4","author":"J Simr\u00e9n","year":"2022","unstructured":"Simr\u00e9n J, Andreasson U, Gobom J, Suarez Calvet M, Borroni B, Gillberg C et al (2022) Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5\u201390 years. Brain Commun 4:fcac174. https:\/\/doi.org\/10.1093\/braincomms\/fcac174","journal-title":"Brain Commun"},{"key":"12066_CR6","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1093\/brain\/awaa342","volume":"143","author":"AL Benedet","year":"2020","unstructured":"Benedet AL, Leuzy A, Pascoal TA, Ashton NJ, Mathotaarachchi S, Savard M et al (2020) Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer\u2019s disease. Brain 143:3793\u20133804. https:\/\/doi.org\/10.1093\/brain\/awaa342","journal-title":"Brain"},{"key":"12066_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jnnp-2015-311387","volume":"87","author":"P Steinacker","year":"2016","unstructured":"Steinacker P, Feneberg E, Weishaupt J, Brettschneider J, Tumani H, Andersen PM et al (2016) Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J Neurol Neurosurg Psychiatry 87:12\u201320. https:\/\/doi.org\/10.1136\/jnnp-2015-311387","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12066_CR8","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/acn3.50890","volume":"6","author":"M De Schaepdryver","year":"2019","unstructured":"De Schaepdryver M, Goossens J, De Meyer S, Jeromin A, Masrori P, Brix B et al (2019) Serum neurofilament heavy chains as early marker of motor neuron degeneration. Ann Clin Transl Neurol 6:1971\u20131979. https:\/\/doi.org\/10.1002\/acn3.50890","journal-title":"Ann Clin Transl Neurol"},{"key":"12066_CR9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3389\/fneur.2018.01167","volume":"9","author":"K Poesen","year":"2019","unstructured":"Poesen K, Van Damme P (2019) Diagnostic and prognostic performance of neurofilaments in ALS. Front Neurol 9:1167. https:\/\/doi.org\/10.3389\/fneur.2018.01167","journal-title":"Front Neurol"},{"key":"12066_CR10","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1212\/WNL.0000000000004761","volume":"90","author":"E Feneberg","year":"2018","unstructured":"Feneberg E, Oeckl P, Steinacker P, Verde F, Barro C, Van Damme P et al (2018) Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis. Neurology 90:e22-30. https:\/\/doi.org\/10.1212\/WNL.0000000000004761","journal-title":"Neurology"},{"key":"12066_CR11","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","volume":"76","author":"C Bridel","year":"2019","unstructured":"Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, the NFL Group (2019) Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol 76:1035\u20131048. https:\/\/doi.org\/10.1001\/jamaneurol.2019.1534","journal-title":"JAMA Neurol"},{"key":"12066_CR12","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/brain\/awac328","volume":"146","author":"S Abu-Rumeileh","year":"2023","unstructured":"Abu-Rumeileh S, Abdelhak A, Foschi M, D\u2019Anna L, Russo M, Steinacker P et al (2023) The multifaceted role of neurofilament light chain protein in non-primary neurological diseases. Brain 146:421\u2013437. https:\/\/doi.org\/10.1093\/brain\/awac328","journal-title":"Brain"},{"key":"12066_CR13","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","volume":"87","author":"JD Rohrer","year":"2016","unstructured":"Rohrer JD, Woollacott IOC, Dick KM, Brotherhood E, Gordon E, Fellows A et al (2016) Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology 87:1329\u20131336. https:\/\/doi.org\/10.1212\/WNL.0000000000003154","journal-title":"Neurology"},{"key":"12066_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Cullen NC, Andreasson U, Zetterberg H, Blennow K (2019) Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease. JAMA Neurol 76:791\u2013799. https:\/\/doi.org\/10.1001\/jamaneurol.2019.0765","journal-title":"JAMA Neurol"},{"key":"12066_CR15","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1007\/s00415-020-09722-6","volume":"267","author":"SN Hayer","year":"2020","unstructured":"Hayer SN, Liepelt I, Barro C, Wilke C, Kuhle J, Martus P et al (2020) NfL and pNfH are increased in Friedreich\u2019s ataxia. J Neurol 267:1420\u20131430. https:\/\/doi.org\/10.1007\/s00415-020-09722-6","journal-title":"J Neurol"},{"key":"12066_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11741-y","author":"L Peng","year":"2023","unstructured":"Peng L, Wan L, Liu M, Long Z, Chen D, Yuan X et al (2023) Diagnostic and prognostic performance of plasma neurofilament light chain in multiple system atrophy: a cross-sectional and longitudinal study. J Neurol. https:\/\/doi.org\/10.1007\/s00415-023-11741-y","journal-title":"J Neurol"},{"key":"12066_CR17","doi-asserted-by":"publisher","first-page":"17368","DOI":"10.1038\/s41598-018-35766-w","volume":"8","author":"Y-S Lin","year":"2018","unstructured":"Lin Y-S, Lee W-J, Wang S-J, Fuh J-L (2018) Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease. Sci Rep 8:17368. https:\/\/doi.org\/10.1038\/s41598-018-35766-w","journal-title":"Sci Rep"},{"key":"12066_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","volume":"25","author":"O Preische","year":"2019","unstructured":"Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C et al (2019) Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease. Nat Med 25:277\u2013283. https:\/\/doi.org\/10.1038\/s41591-018-0304-3","journal-title":"Nat Med"},{"key":"12066_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12549","author":"D Eratne","year":"2022","unstructured":"Eratne D, Loi SM, Li Q-X, Stehmann C, Malpas CB, Santillo A et al (2022) Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer\u2019s disease and frontotemporal disorders in clinical settings. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12549","journal-title":"Alzheimers Dement"},{"key":"12066_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00415-019-09567-8","volume":"267","author":"K Katisko","year":"2020","unstructured":"Katisko K, Cajanus A, J\u00e4\u00e4skel\u00e4inen O, Kontkanen A, Hartikainen P, Korhonen VE et al (2020) Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders. J Neurol 267:162\u2013167. https:\/\/doi.org\/10.1007\/s00415-019-09567-8","journal-title":"J Neurol"},{"key":"12066_CR21","doi-asserted-by":"publisher","first-page":"e860","DOI":"10.1212\/WNL.0000000000201597","volume":"100","author":"J Sarto","year":"2023","unstructured":"Sarto J, Ruiz-Garc\u00eda R, Guill\u00e9n N, Ramos-Campoy \u00d3, Falg\u00e0s N, Esteller D et al (2023) Diagnostic performance and clinical applicability of blood-based biomarkers in a prospective memory clinic cohort. Neurology 100:e860\u2013e873. https:\/\/doi.org\/10.1212\/WNL.0000000000201597","journal-title":"Neurology"},{"key":"12066_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12986","author":"PCL Ferreira","year":"2023","unstructured":"Ferreira PCL, Zhang Y, Snitz B, Chang CCH, Bellaver B, Jacobsen E et al (2023) Plasma biomarkers identify older adults at risk of Alzheimer\u2019s disease and related dementias in a real-world population-based cohort. Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12986","journal-title":"Alzheimers Dement"},{"key":"12066_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105937","volume":"176","author":"K G\u00f6tze","year":"2023","unstructured":"G\u00f6tze K, Vrillon A, Bouaziz-Amar E, Mouton-Liger F, Hugon J, Martinet M et al (2023) Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study. Neurobiol Dis 176:105937. https:\/\/doi.org\/10.1016\/j.nbd.2022.105937","journal-title":"Neurobiol Dis"},{"key":"12066_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.14.22269323","author":"D Eratne","year":"2022","unstructured":"Eratne D, Keem M, Lewis C, Kang M, Walterfang M, Loi S et al (2022) Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from \u2018phenocopy\u2019 non-progressors. Neurology. https:\/\/doi.org\/10.1101\/2022.01.14.22269323","journal-title":"Neurology"},{"key":"12066_CR25","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1515\/cclm-2019-0015","volume":"57","author":"C Wilke","year":"2019","unstructured":"Wilke C, Pujol-Calder\u00f3n F, Barro C, Stransky E, Blennow K, Michalak Z et al (2019) Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches. Clin Chem Lab Med 57:1556\u20131564. https:\/\/doi.org\/10.1515\/cclm-2019-0015","journal-title":"Clin Chem Lab Med"},{"key":"12066_CR26","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10714-3","author":"J Escal","year":"2021","unstructured":"Escal J, Fourier A, Formaglio M, Zimmer L, Bernard E, Mollion H et al (2021) Comparative diagnosis interest of NfL and pNfH in CSF and plasma in a context of FTD\u2013ALS spectrum. J Neurol. https:\/\/doi.org\/10.1007\/s00415-021-10714-3","journal-title":"J Neurol"},{"key":"12066_CR27","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1212\/WNL.0000000000009559","volume":"95","author":"M Benatar","year":"2020","unstructured":"Benatar M, Zhang L, Wang L, Granit V, Statland J, Barohn R et al (2020) Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology 95:e59-69. https:\/\/doi.org\/10.1212\/WNL.0000000000009559","journal-title":"Neurology"},{"key":"12066_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/ana.24980","volume":"82","author":"TF Gendron","year":"2017","unstructured":"Gendron TF, Daughrity LM, Heckman MG, Diehl NN, Wuu J, C9ORF72 Neurofilament Study Group et al (2017) Phosphorylated neurofilament heavy chain: a biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis. Ann Neurol 82:139\u2013146. https:\/\/doi.org\/10.1002\/ana.24980","journal-title":"Ann Neurol"},{"key":"12066_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1080\/21678421.2019.1646769","volume":"20","author":"M Benatar","year":"2019","unstructured":"Benatar M, Wuu J, Lombardi V, Jeromin A, Bowser R, Andersen PM et al (2019) Neurofilaments in pre-symptomatic ALS and the impact of genotype. Amyotroph Lateral Scler Frontotemporal Degener 20:538\u2013548. https:\/\/doi.org\/10.1080\/21678421.2019.1646769","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12066_CR30","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1007\/s00415-022-11504-1","volume":"270","author":"D Baumgartner","year":"2023","unstructured":"Baumgartner D, Mazanec R, Hanzalov\u00e1 J (2023) Diagnostic utility of neurofilament markers for MND is limited in restricted disease phenotype and for differentiation from compressive myeloradiculopathies. J Neurol 270:1600\u20131614. https:\/\/doi.org\/10.1007\/s00415-022-11504-1","journal-title":"J Neurol"},{"key":"12066_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/ana.20006","volume":"55","author":"G Rossi","year":"2004","unstructured":"Rossi G, Gasparoli E, Pasquali C, Di Fede G, Testa D, Albanese A et al (2004) Progressive supranuclear palsy and Parkinson\u2019s disease in a family with a new mutation in the tau gene. Ann Neurol 55:448. https:\/\/doi.org\/10.1002\/ana.20006","journal-title":"Ann Neurol"},{"key":"12066_CR32","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1007\/s00415-020-09838-9","volume":"267","author":"YM Falzone","year":"2020","unstructured":"Falzone YM, Domi T, Agosta F, Pozzi L, Schito P, Fazio R et al (2020) Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease. J Neurol 267:2272\u20132280. https:\/\/doi.org\/10.1007\/s00415-020-09838-9","journal-title":"J Neurol"},{"key":"12066_CR33","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/jnnp.2006.107326","volume":"78","author":"D de Jong","year":"2007","unstructured":"de Jong D, Jansen RWMM, Pijnenburg YAL, van Geel WJA, Borm GF, Kremer HPH et al (2007) CSF neurofilament proteins in the differential diagnosis of dementia. J Neurol Neurosurg Psychiatry 78:936\u2013938. https:\/\/doi.org\/10.1136\/jnnp.2006.107326","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12066_CR34","doi-asserted-by":"publisher","first-page":"22128","DOI":"10.1038\/s41598-021-01499-6","volume":"11","author":"A Behzadi","year":"2021","unstructured":"Behzadi A, Pujol-Calder\u00f3n F, Tjust AE, Wuolikainen A, H\u00f6glund K, Forsberg K et al (2021) Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics. Sci Rep 11:22128. https:\/\/doi.org\/10.1038\/s41598-021-01499-6","journal-title":"Sci Rep"},{"key":"12066_CR35","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","volume":"88","author":"K Poesen","year":"2017","unstructured":"Poesen K, De Schaepdryver M, Stubendorff B, Gille B, Muckova P, Wendler S et al (2017) Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology 88:2302\u20132309. https:\/\/doi.org\/10.1212\/WNL.0000000000004029","journal-title":"Neurology"},{"key":"12066_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-327129","author":"S Halbgebauer","year":"2021","unstructured":"Halbgebauer S, Steinacker P, Verde F, Weishaupt J, Oeckl P, von Arnim C et al (2021) Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2021-327129","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12066_CR37","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:270\u2013279. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008","journal-title":"Alzheimers Dement"},{"key":"12066_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"key":"12066_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement 14:535\u2013562. https:\/\/doi.org\/10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"12066_CR40","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006\u20131014. https:\/\/doi.org\/10.1212\/WNL.0b013e31821103e6","journal-title":"Neurology"},{"key":"12066_CR41","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456\u20132477. https:\/\/doi.org\/10.1093\/brain\/awr179","journal-title":"Brain"},{"key":"12066_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies. Neurology 89:88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058","journal-title":"Neurology"},{"key":"12066_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/WAD.0000000000000034","volume":"28","author":"P Sachdev","year":"2014","unstructured":"Sachdev P, Kalaria R, O\u2019Brien J, Skoog I, Alladi S, Black SE et al (2014) Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord 28:206\u2013218. https:\/\/doi.org\/10.1097\/WAD.0000000000000034","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"12066_CR44","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","volume":"55","author":"P Scheltens","year":"1992","unstructured":"Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P et al (1992) Atrophy of medial temporal lobes on MRI in \u201cprobable\u201d Alzheimer\u2019s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967\u2013972. https:\/\/doi.org\/10.1136\/jnnp.55.10.967","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12066_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13195-019-0550-8","volume":"11","author":"MJ Leit\u00e3o","year":"2019","unstructured":"Leit\u00e3o MJ, Silva-Sp\u00ednola A, Santana I, Olmedo V, Nadal A, Le Bastard N et al (2019) Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer\u2019s disease. Alzheimers Res Ther 11:91. https:\/\/doi.org\/10.1186\/s13195-019-0550-8","journal-title":"Alzheimers Res Ther"},{"key":"12066_CR46","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nbt.1641","volume":"28","author":"DM Rissin","year":"2010","unstructured":"Rissin DM, Kan CW, Campbell TG, Howes SC, Fournier DR, Song L et al (2010) Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28:595\u2013599. https:\/\/doi.org\/10.1038\/nbt.1641","journal-title":"Nat Biotechnol"},{"key":"12066_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0339-1","author":"L Gaetani","year":"2018","unstructured":"Gaetani L, H\u00f6glund K, Parnetti L, Pujol-Calderon F, Becker B, Eusebi P et al (2018) A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation. Alzheimers Res Ther. https:\/\/doi.org\/10.1186\/s13195-018-0339-1","journal-title":"Alzheimers Res Ther"},{"key":"12066_CR48","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00415-014-7335-6","volume":"261","author":"J Dumurgier","year":"2014","unstructured":"Dumurgier J, Laplanche J-L, Mouton-Liger F, Lapalus P, Indart S, Pr\u00e9vot M et al (2014) The screening of Alzheimer\u2019s patients with CSF biomarkers, modulates the distribution of APOE genotype: impact on clinical trials. J Neurol 261:1187\u20131195. https:\/\/doi.org\/10.1007\/s00415-014-7335-6","journal-title":"J Neurol"},{"key":"12066_CR49","doi-asserted-by":"publisher","DOI":"10.17877\/DE290R-12739","author":"M Eid","year":"2010","unstructured":"Eid M, Gollwitzer M, Schmitt M (2010) Statistik und Forschungsmethoden. Technische Universit\u00e4t Dortmund. https:\/\/doi.org\/10.17877\/DE290R-12739","journal-title":"Technische Universit\u00e4t Dortmund"},{"key":"12066_CR50","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/oxfordjournals.aje.a009137","volume":"145","author":"H Jacqmin-Gadda","year":"1997","unstructured":"Jacqmin-Gadda H, Fabrigoule C, Commenges D, Dartigues JF (1997) A 5-year longitudinal study of the mini-mental state examination in normal aging. Am J Epidemiol 145:498\u2013506. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009137","journal-title":"Am J Epidemiol"},{"key":"12066_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jns.2016.05.062","volume":"367","author":"S Li","year":"2016","unstructured":"Li S, Ren Y, Zhu W, Yang F, Zhang X, Huang X (2016) Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis. J Neurol Sci 367:269\u2013274. https:\/\/doi.org\/10.1016\/j.jns.2016.05.062","journal-title":"J Neurol Sci"},{"key":"12066_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2021-000143","volume":"3","author":"J Alagaratnam","year":"2021","unstructured":"Alagaratnam J, von Widekind S, De Francesco D, Underwood J, Edison P, Winston A et al (2021) Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis. BMJ Neurol Open 3:e000143. https:\/\/doi.org\/10.1136\/bmjno-2021-000143","journal-title":"BMJ Neurol Open"},{"key":"12066_CR53","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.brainres.2010.01.075","volume":"1322","author":"J Kushkuley","year":"2010","unstructured":"Kushkuley J, Metkar S, Chan WK-H, Lee S, Shea TB (2010) Aluminum induces neurofilament aggregation by stabilizing cross-bridging of phosphorylated c-terminal sidearms. Brain Res 1322:118\u2013123. https:\/\/doi.org\/10.1016\/j.brainres.2010.01.075","journal-title":"Brain Res"},{"key":"12066_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jneumeth.2010.11.026","volume":"195","author":"C-H Lu","year":"2011","unstructured":"Lu C-H, Kalmar B, Malaspina A, Greensmith L, Petzold A (2011) A method to solubilise protein aggregates for immunoassay quantification which overcomes the neurofilament \u201chook\u201d effect. J Neurosci Methods 195:143\u2013150. https:\/\/doi.org\/10.1016\/j.jneumeth.2010.11.026","journal-title":"J Neurosci Methods"},{"key":"12066_CR55","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","volume":"11","author":"M Khalil","year":"2020","unstructured":"Khalil M, Pirpamer L, Hofer E, Voortman MM, Barro C, Leppert D et al (2020) Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun 11:812. https:\/\/doi.org\/10.1038\/s41467-020-14612-6","journal-title":"Nat Commun"},{"key":"12066_CR56","doi-asserted-by":"publisher","first-page":"e1390","DOI":"10.1212\/WNL.0000000000006318","volume":"91","author":"P Steinacker","year":"2018","unstructured":"Steinacker P, Anderl-Straub S, Diehl-Schmid J, Semler E, Uttner I, von Arnim CAF et al (2018) Serum neurofilament light chain in behavioral variant frontotemporal dementia. Neurology 91:e1390\u2013e1401. https:\/\/doi.org\/10.1212\/WNL.0000000000006318","journal-title":"Neurology"},{"key":"12066_CR57","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","volume":"269","author":"G Giacomucci","year":"2022","unstructured":"Giacomucci G, Mazzeo S, Bagnoli S, Ingannato A, Leccese D, Berti V et al (2022) Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in subjective cognitive decline and mild cognitive impairment. J Neurol 269:4270\u20134280. https:\/\/doi.org\/10.1007\/s00415-022-11055-5","journal-title":"J Neurol"},{"key":"12066_CR58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/jnnp-2017-316605","volume":"89","author":"M De Schaepdryver","year":"2018","unstructured":"De Schaepdryver M, Jeromin A, Gille B, Claeys KG, Herbst V, Brix B et al (2018) Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 89:367\u2013373. https:\/\/doi.org\/10.1136\/jnnp-2017-316605","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12066_CR59","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3109\/21678421.2016.1167913","volume":"17","author":"P Oeckl","year":"2016","unstructured":"Oeckl P, Jardel C, Salachas F, Lamari F, Andersen PM, Bowser R et al (2016) Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotroph Lateral Scler Frontotemporal Degener 17:404\u2013413. https:\/\/doi.org\/10.3109\/21678421.2016.1167913","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12066_CR60","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/s0092-8674(01)00244-6","volume":"104","author":"JP Julien","year":"2001","unstructured":"Julien JP (2001) Amyotrophic lateral sclerosis. Unfolding the toxicity of the misfolded. Cell 104:581\u2013591. https:\/\/doi.org\/10.1016\/s0092-8674(01)00244-6","journal-title":"Cell"},{"key":"12066_CR61","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/00005072-199910000-00009","volume":"58","author":"J Meier","year":"1999","unstructured":"Meier J, Couillard-Despr\u00e9s S, Jacomy H, Gravel C, Julien JP (1999) Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice. J Neuropathol Exp Neurol 58:1099\u20131110","journal-title":"J Neuropathol Exp Neurol"},{"key":"12066_CR62","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00005072-198409000-00002","volume":"43","author":"A Hirano","year":"1984","unstructured":"Hirano A, Nakano I, Kurland LT, Mulder DW, Holley PW, Saccomanno G (1984) Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 43:471\u2013480. https:\/\/doi.org\/10.1097\/00005072-198409000-00002","journal-title":"J Neuropathol Exp Neurol"},{"key":"12066_CR63","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1212\/WNL.0000000000007767","volume":"93","author":"MM Mielke","year":"2019","unstructured":"Mielke MM, Syrjanen JA, Blennow K, Zetterberg H, Vemuri P, Skoog I et al (2019) Plasma and CSF neurofilament light: relation to longitudinal neuroimaging and cognitive measures. Neurology 93:e252\u2013e260. https:\/\/doi.org\/10.1212\/WNL.0000000000007767","journal-title":"Neurology"},{"key":"12066_CR64","doi-asserted-by":"publisher","first-page":"e1315","DOI":"10.1212\/WNL.0000000000200035","volume":"98","author":"JL Ebenau","year":"2022","unstructured":"Ebenau JL, Pelkmans W, Verberk IMW, Verfaillie SCJ, van den Bosch KA, van Leeuwenstijn M et al (2022) Association of CSF, plasma, and imaging markers of neurodegeneration with clinical progression in people with subjective cognitive decline. Neurology 98:e1315\u2013e1326. https:\/\/doi.org\/10.1212\/WNL.0000000000200035","journal-title":"Neurology"},{"key":"12066_CR65","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K (2017) Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol 74:557\u2013566. https:\/\/doi.org\/10.1001\/jamaneurol.2016.6117","journal-title":"JAMA Neurol"},{"key":"12066_CR66","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/ane.13078","volume":"139","author":"P de Flon","year":"2019","unstructured":"de Flon P, Laurell K, Sundstr\u00f6m P, Blennow K, S\u00f6derstr\u00f6m L, Zetterberg H et al (2019) Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial. Acta Neurol Scand 139:462\u2013468. https:\/\/doi.org\/10.1111\/ane.13078","journal-title":"Acta Neurol Scand"},{"key":"12066_CR67","doi-asserted-by":"publisher","first-page":"10787","DOI":"10.3390\/ijms241310787","volume":"24","author":"A Pafiti","year":"2023","unstructured":"Pafiti A, Krashias G, Tzartos J, Tzartos S, Stergiou C, Gaglia E et al (2023) A comparison of two analytical approaches for the quantification of neurofilament light chain, a biomarker of axonal damage in multiple sclerosis. Int J Mol Sci 24:10787. https:\/\/doi.org\/10.3390\/ijms241310787","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-12066-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-12066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T03:05:04Z","timestamp":1708916704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-12066-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,11]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["12066"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-12066-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,11]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HZ has served at scientific advisory boards for Alector, Eisai, Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics, Nervgen, AZTherapies and CogRx, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). CP is a member of the International Advisory Boards of Lilly; is a consultant for Fujiribio, Alzhois, Neuroimmune, Ads Neuroscience, Roche, AgenT and Gilead; and is involved as an investigator in several clinical trials for Roche, Esai, Lilly, Biogen, Astra-Zeneca, Lundbeck, and Neuroimmune. KB has served as a consultant and at advisory boards for Acumen, ALZPath, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Novartis, Ono Pharma, Prothena, Roche Diagnostics, and Siemens Healthineers; has served at data monitoring committees for Julius Clinical and Novartis; has given lectures, produced educational materials and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Progra (outside submitted work).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This research study was approved by the local ethics committee of Bichat Hospital, Paris, France (CEERB GHU Nord no.10-037).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patients who participated in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}